<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjms</journal-id><journal-id journal-id-type="pubmed">IARJMS</journal-id><journal-id journal-id-type="publisher">IARJMS</journal-id><issn>2708-3594</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iarjms.2023.v04i01.043</article-id><title-group><article-title>Prevention of Rheumatoid Arthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>Sushma</given-names><surname>Devi</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Rahul</given-names><surname>Ranta</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Ritika</given-names></name></contrib></contrib-group><aff-id id="aff-a" /><abstract>Although early RA treatment improves results, the ultimate objective of RA management should be disease prevention. The rising body of research showing that RA-specific indicators appear before the onset of clinically evident RA makes the idea of preventing RA more alluring and feasible to achieve. However, what is meant by RA prevention will vary depending on the investigator. It might entail identifying those who have developed RA-related autoimmunity without overt IA and putting medicines into place to stop the disease from progressing. Lastly, it can entail modifying RA-related risk factors at the individual or population level to stop the disease from developing in the future. Below, methods for each of these sorts of prevention are covered in further detail.</abstract></article-meta></front><body /><back /></article>